Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Scott Bowden

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Hepatology|January 27, 2011
Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver diseaseMark D Berzsenyi, David J Woollard, Catriona A McLean, et al.
Journal of Gastroenterology and Hepatology|July 5, 2007
Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factorsAlexander J V Thompson, Anna Ayres, Lilly Yuen, et al.
Journal of Gastroenterology and Hepatology|January 11, 2013
IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-αJacinta A Holmes, Tin Nguyen, Dilip Ratnam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2012
A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009Ellen J Donnan, James E Fielding, Joy E Gregory, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological responseJacinta A Holmes, Stuart K Roberts, Rachel J Ali, et al.
Transplantation|February 24, 2015
Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody MicroarraysWassim Rahman, Thomas Tu, Magdalena Budzinska, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2022
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levelsSamuel A L Hall, Gareth S Burns, Despina Anagnostou, et al.
Hepatology Communications|July 17, 2023
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participantsAlexander J Thompson, Kathy Jackson, Sara Bonanzinga, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Hepatology|January 27, 2011
Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver diseaseMark D Berzsenyi, David J Woollard, Catriona A McLean, et al.
Journal of Gastroenterology and Hepatology|July 5, 2007
Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factorsAlexander J V Thompson, Anna Ayres, Lilly Yuen, et al.
Journal of Gastroenterology and Hepatology|January 11, 2013
IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-αJacinta A Holmes, Tin Nguyen, Dilip Ratnam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2012
A multistate outbreak of hepatitis A associated with semidried tomatoes in Australia, 2009Ellen J Donnan, James E Fielding, Joy E Gregory, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological responseJacinta A Holmes, Stuart K Roberts, Rachel J Ali, et al.
Transplantation|February 24, 2015
Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody MicroarraysWassim Rahman, Thomas Tu, Magdalena Budzinska, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2022
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levelsSamuel A L Hall, Gareth S Burns, Despina Anagnostou, et al.
Hepatology Communications|July 17, 2023
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participantsAlexander J Thompson, Kathy Jackson, Sara Bonanzinga, et al.
Pageof 2